Talis Biomedical has leased space in the Redwood LIFE office park in
Redwood City.
REDWOOD CITY — A fast-expanding life sciences firm with a new COVID test
has found more elbow room in Silicon Valley with a new lease, brokers
said Wednesday.
Fresh from an initial public offering of its stock that raised $245
million, Talis Biomedical says it has a rapid and accurate testing system
to detect SARS-CoV-2, the virus that causes COVID-19.
“Talis is in an exciting growth phase as we scale-up for the commercial
launch of the Talis One for COVID-19 and planned expansion of our test
menu to include other infectious diseases,” said Brian Coe, chief
executive officer of Talis. …
